Lv1
10 积分 2025-10-14 加入
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
15天前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
15天前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
1个月前
已完结
Generalizable AI predicts immunotherapy outcomes across cancers and treatments
1个月前
已完结
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
1个月前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
3个月前
已完结
Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study
3个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
3个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
3个月前
已关闭
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
3个月前
已关闭
皖公网安备34019202002308
